Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

P2 > Fetal medicine > Flashcards

Fetal medicine Flashcards

1
Q

Definition of FGR vs SGA vs IUGR

A

FGR = EFW <10%
SGA (isolated FGR) = physiologically small
IUGR = EFW <10%, abnormal dopplers/ AFI, poor growth velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antenatal monitoring for those with known IUGR risk factors

A

Growth
AF
UAD from 26/40 every 2-4/52
Consider aspirin if risk factors present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Incidence and outcome of IUGR

A

Affects 10% pregnancies
Recurrence 25%
70% normal outcome
if EFW <3%, significant increase in adverse perinatal outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Monitoring diagnosed IUGR

A

Growth scan every 2/52
If raised dopplers (PI > 95%) = increase monitoring to weekly, UAD every second week
AEDF <34/40 - admit, daily CTG, twice weekly AFI + UAD
REDF <30/40 - admit, daily CTG, AFI/ UAD 3x/week, +/- fetal med opinion
MCA and DV can be measured - not used for delivery timing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Delivery in IUGR

A

Consider timed steroids - 24-34/40 and up to 38/40 in some situations
AEDF - delivery </= 34/40 or sooner if poor growth/ dec AFI
Isolated FGR w normal LV/ UAD - deliver 37/40 or up to 38-39/40
If <32/40, consider MgSO4
Continuous CTG in labour w abnormal UAD, low threshold for CS
Cord gases and placenta for histology
MOD - individual basis decision. CS advised if AEDF or very PT
PN counselling if <34/40 - review of placenta and thrombophilia screen, future pregnancy plan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Women at high risk for pre-eclampsia

A

Hypertensive disease in prev pregnancy
Chronic kidney disease
Autoimmune disase
T1 or T2 diabetes
Chronic hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Moderate risk factors for pre-eclampsia

A

First pregnancy
Age 40+
Pregnancy interval of >10 years
BMI >35
FH PET
Multi-fetal pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Definition of dopplers, absent end and reverse

A

Doppler: uses sound waves to determine flor and velocity of blood flow in a vessel, shift in observed frequency of a wave due to motion
AEDF - no flow towards fetus in diastole
REDF - blood flow away from fetus during diastole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of abnormal dopplers

A

Maternal:
- medical dx
- prev SGA
- poor weight gain/ excessive exercise
- uterine anomalies
- ERT
Paternal:
- low birthweight
Fetal:
- female
- chromosomal
- malformations
- infections
- multiple fetuses
Placental:
- developmental abnormalities
- cord coil
- infarction
- villisitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risks to baby in the neonatal period with detected abnormal dopplers

A

increased risk CS
Low BSL after delivery
Hypoxia during delivery
Admission to SCBU
Meconium aspiration
Increased risk of motor and neurological abnormalities
Feeding difficulties
NEC
Sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fetal anaemia - definition

A

Normal fetal Hb shoudl increase throughout GA - 150g/L at 40/40
Anaemia: > 70g/L below mean for gestation
Hydrops zone - gestation dependent. Ranges from fHb <40g/L at 18/40 to fHb 80g/L at 40/40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Implications of fetal anaemia

A

Reduced tissue perfusion –> brain injury, cardiac failure, IUFD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of fetal anaemia

A

MC: alloimmune red cell destruction
MC non-immune infectious red cell destruction - parvovirus
Others:
disorders of fetal red cell production
fetal haemorrhage
fetal tumours
complications of monochorionicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Definition and incidence of red cell alloimmunisation

A

Haemolytic disease of the fetus and newborn (HDFN) - occurs after a woman is exposed to a mismatch of paternally derived RBC antigens from fetus
Affects 1 in 300-600 live births
RBC alloantibodies present in 1 in 80 pregnant women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of red cell alloimmunisation

A

Sensitizing events
Blood transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Types of rhesus antibodies

A

D, c, E K
D - antiD reduced D-alloimmunisation to 2%
Anti-E most prevalent
Rare - K (Kepp group) - can cause severe, early onset anaemia –> suppresses erythropoesis and RC destruction
If incompatibility with Rh D, c and E –> severe HDFN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why does Rh affect second pregnancy and not the first

A

First responmse IgM can’t cross the placenta
Second response IgG - can cross, therefore affecting subsequent pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antenatal screening for RC alloimmunisation

A

Booking and 28/40 G&H for antibody status
+/- fetal genotyping depending on unit
cffDNA - diagnostic for RC antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Monitoring in cases with RC alloimmunisation

A

Blood test 4 weekly up to 28/40, then 2 weekly until delivery
Levels and titre measured
Kell AB - low threshold for referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prevention of alloimmunisation

A

RAADP prophylactic doses - 28/40, postnatally
AntiD within 72 hours of sensitizing event
1 500iu dose anti-D sufficient to cover 4ml of fetal RBCs
Kleihauer-Betke test confirms fetal-maternal haemorrhage (FMH)
Sensitization can occur with silent FMH, failure to administer antiD or if too small a dose given
Large FMH - needs 125u/ml
Max dose 10000units/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Parvovirus spread and consequences

A

ssDNA virus
Spread via resp droplets
More than 1/2 population immune
Infection in first 1/2 pregnancy - fetal anaemia and hydrops - d/t viral destruction of fetal erythroid progenitor cells
Fetal loss: <20/40 - 13%, > 20/40 0.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CMV testing

A

Avidity testing - tests strength of IgG and antigen complex
Gradually increasing with time after primary infection –> latency of infection
Low acidity = recent infection
2% associated with reactivation after previous primary infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

USS signs of congenital infection

A

Echogenic bowel
Hepatic calcifications
Organomegaly
Dysplastic kidneys
Ventriculomegaly
FGR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Disorders of fetal erythropoeisis

A

Aplastic anaemia
Thalassaemia
Genetic disorders - porphyria, fanconi anaemia, G6PD
Vascular tumours
Fetomaternal haemorrhage
Vasa praevia
Monochorionicity - twin anaemia polycythaemia sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Barts hydrops fetalis

A

Complication seen in fetus born to two parents with alpha thalassaemia trait (1 in 4 major)
Occurs in the absence of any normal Hb
Classic US sign: thickened placenta
Fetal features:
- severe pallor, generalised oedema and massive HSM
- signs of fetal distress usually evident by third trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

TAPS

A

Twin anaemia polycythaemia sequence
- occurs in monochorionic twins
- similar to TTTS but placental connections smaller
- small caliber AV anastomoses occur, typically near the edge of the placenta, <1mm in diameter
- normal AFI, unlike TTTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Who to refer to fetal medicine- re RC alloimmunisation

A

Rising antibody titres/ above specific threshold
USS features
Unexplained severe neonatal jaundice/ anaemia with HDFN excluded
Ab other than anti-D, anti-C, anti-K
Hx prev significant HDFN/ OUT/ titre >/=32
Anti-D >4iu but <15 = moderate reisk/ >15iu = severe HDFN
ANti-c >7.5iu/ml but <30 = moderate risk/ >30 = high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Identifying fetus with fetal anaemia

A

High risk - booking hx, G&H, screening, USS
Diagnosis: direct fetal blood sampling
Doppler MCA-PSV - >1.5MoM = action
Hydrops: effusions, ascites, oedema, poly
MRI to estimate fetal haematocrit
CTG - sinusoidal pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Process of intrauterine transfusion

A

US guided percutaneous needle (2-22G)
via umbilical vein
Intraperitoneal fetal transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Medical treatment fetal anaemia

A

IvIG - blocks transprt of alloantibodies across the placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Neonatal Outcomes assoc with fetal anaemia

A

cord bloods of at risk neonates - direct antiglobuylin test, Hb, bilirubin
Antibodies remain for 6 months - continuing RC destruction –> chronic unconjugated hyperbilirubinaemia and brain injury (kernicterus)
Early neonatal anaemia in HDFN (w/in 7/7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Hydrops fetalis -

A

excess fluid in more than one body cavity - subcutaneous oedema, pleural effusion, pericardial effusion, ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Maternal risk factors for hydrops

A

Racial background
Prev pregnancy
Genetic FHx
Consanguity
Illness or contact with illness during pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Causes of hydrops

A

Isoimmunisation
Chromosomal - trisomies, turners
Anaemia - alpha thalassaemia, chronic FMH
Genetic
CVS - structural, tachyarrythmias
Pulmonary - diaphragmatic hernia
Cystic hygroma
Infections - parvo/ CMV/ syphilis/ coxI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Investigations in hydrops

A

Blood group and ab screen
Haemoglobinopathy screen
TORCH and parvo screen
Syphilis serologyu
Coxsackie
Kleihauer
US - other abnormalities, MCA doppler, amnio for karyotype and virology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Rh sensitizing events

A

Delivery
ERPC
CVS
Amnio
ECV
Miscarriage >12/40
APH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Treatment hydrops

A

IU transfusions for isoimmunisation and parve
Syphilis - hugh dose penicillin
Cox - resolve spontaneously
CMV - poor outcome
Tachyarrhthmia - antiarrhythmics
Termination - karyotyping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Incidence gastroschisis

A

1-6 per 10000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Incidence omphalocoele

A

1 in 4000-7000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Risk factors for omphalocoele

A

AMA>40
Obesity
Smokng
ETOH
SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is an omphalocoele

A

Abdominal wall defect - bowel +/- other abdominal organs protrude within a thin layered sac, near the base of the umbilical cord
Defect usually 4-12cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Differentials for omphalocoele

A

Gastroschisis
Cloacal extrophy
physiological gut herniation
Hernia of the cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Aetiology of omphalocoele

A

in early pregnancy- organs form outside the body and return to the abdominal cavity by 11/40- failure–> omphalocoele
Not genetic; appears sporadic
Can be a part of a genetic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Defects associated with omphalocoele

A

Abdo, Cardiac, neuro, gu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Chromosomal abnormalities associated with omphalocoele

A

Trisomy 13, 18, 21
45XO
Klinefelter
Triploidy
Brockwith-Wiedeman syndrome
Pentology of Cantrell
OEIS complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Types of omphalocoele

A

Small: bowel only
- associated with genetic syndromes - T18, T13, T21, Turners, aneuploidy
Large: includes other organs
- more likely associated with pulm hypoplasia, 1/3 also have cardiac anomalies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Diagnosing omphalocoele

A

Increased AFP in T1
USS + growth surveillance
Amnio/ NIPT
Fetal echo/ MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is a Schuster procedure

A

Staged surgical repair for large omphalocoele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Risk factors for gastroschisis

A

Mat age <20
Smoking
Env exposures- nitrosamines
Maternal COX inhibitors (aspirin/ ibuprofen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Definition of gastroschisis

A

Full thickness abdominal wall defect with no protective membrane. Direct intestinal exposure to amniotic fluid –> chemical reactions –> thick inflammatory film covering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Aetiology of gastroschisis

A

Exact mechanism unknown
- ?compromise vascular supply to anterior wall
- ?defect in the primordial umbilical ring
- ? abnormal involution of the right umbilical vein–> weakened point at risk of rupture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Differentials for gastroschisis

A

Omphalocoele
Cloacal extrophy
physiological gut herniation

53
Q

Features of gastroschisis

A

Visible at birth and on USS at 20/40
Often to the right of the UC
Involves intestines, liver, stomach
Swollen, inflamed, thickened tissue
Thick fibrous peel
Abdo cavity smaller than expected
Assoc w intestinal malrotation
10-15% intestinal atresia due to small size of abdo defect
Extra-structural anomalies not commonly associated

54
Q

Diagnosing gastroschisis

A

IncreasedAFP in T1
Free floating bowel on USS and growth scans

55
Q

Incidence of isolated single umbilical artery (SUA)

A

1% singleton/5% twin pregnancy
Usually left artery absent

56
Q

Relevant prev pregnancy hx in SUA

A

Congenital anomalies
Any teratogens in pregnancy (nb phenytoin)
Medical hx-hyperglycaemia

57
Q

Incidence of SUA with other anomalies

A

9%

58
Q

Anomalies assoc with SUA

A

Renal/CVS/ GI/ CNS
NB to do fetal echo and karyotyping if non-isolated/ abnormal screening or IUGR

59
Q

Genetic syndromes assoc w SUA

A

VATER complexx/ VACTERL
Meckel-Gruber
Zellweger

60
Q

Pathophysiology diaphragmatic hernia

A

Either Bochdalek or Morgagni
Bochdalek more common - 1 in 5000
- defect in posterior attachmen
- left-sided
Morgagni
- herniation at foramen of Morgagni
- anterior and rightsided

61
Q

Congenital anomalies/ syndromes assoc with Bochdalek hernia

A

1/3 cases assoc w other congenital anomalies
Donnal-Barrow syndrome
Fryns syndrome
Pallister-Killian mosaic syndrome

62
Q

Clinical features of diaphragmatic hernia

A

Congenital - asymptomatic
May present in the perinatal period
In utero:
- pulmonary hypoplasia
- respiratory compromise
At birth:
- dyspnoea
- chest pain
- bowel obstruction
Bochdalek: most are small

63
Q

Incidence of double bubble sign

A

1 in 5000

64
Q

Causes of double bubble sign

A

Congenital obstruction:
- duodenal web
- duodenal atresia
- duodenal stenosis
- angular pancreas
Volvulus
External compression:
- choledochal cyst
- mesenteric duplication cyst
- intramural duodenal haematoma
-preduodenal portal vein
- retroperitoneal tumour
- SMA syndrome

65
Q

Anomalies associated with double bubble sign

A

Chromosomal
- T21:in 30%
Other defects- cardiac, renal, vertebral in 10-20%

66
Q

USS interpretation of double bubble sign

A

Represents dilatation or swelling or the duodenum and stomach
seen at >24/40
Polyhydramnios noted in 50% cases

67
Q

Investigations in light of double bubble sign

A

Detailed USS and ECHO
Aneuploidy testing
Growth and AFI scans every 2-3 weeks

68
Q

Delivery if double bubble sign present

A

IOL at 38/40
NICU + paeds

68
Q

Incidence cystic hygroma

A

1 in 8000

69
Q

Symptoms of cystic hygroma

A

Ingestion issues
Airway obstruction

70
Q

Genetic associations of cystic hygroma

A

Turners
Downs
Noonan

70
Q

Investigations when cystic hygroma noted

A

Prenatal: CVS, amnio
Postnatal: CXR, CT, MRI

70
Q

Complications of cystic hygroma

A

Airway
Facial deformity
Cellulitis
Surgical complications - nerve damage, heavy bleeding
Recurrence

71
Q

Features of parvovirus

A

Causes slapped cheek syndrome/ fifth disease/ erythema infectiosum
ssDNA virus
Incubation: 4-20 days
50-65% population immune
Spread via droplets/ hand-to-hand

72
Q

Symptoms of parvovirus infection

A

Asymptomatic 20-25%
Flu-like
Fever
Rash
Arthralgia
Rare sx: anaemia, myocarditis, aplastic crisis

73
Q

Diagnosis parvovirus

A

B19 IgG+ andIgM neg

74
Q

Things to do if confirmed parvovirus infection

A

Inform public health
IgM and DNA
IgM repeated if negative= outside incubation -repeat 2/52
Placental passage rates 17-33%

75
Q

Fetal effects of parvovirus

A

Affects 10%
Fetal sx occur 6/52 post infection
Most vulnerable in 2nd trimester (17-24/40)
Spontaneous abortion (10% above baseline)
Hydrops fetalis (accounts for 8-10% of non-immune hydrops)
- severe anaemia, hypoxia, high output cardiac failure
- impaired hepatic function, direct damage to hepatocytes and indirect via haemosiderin deposits

76
Q

USS features noted in parvovirus

A

Ascites
Skin oedema
Pleural and pericardial effusions
Placental oedema

77
Q

Longterm complications parvovirus infection

A

Hepatic insufficiency
Myocarditis
Anaemia
CNS effects

78
Q

Monitoring in known parvovirus infection

A

Serial fetal med USS weekly x 8-1/52 (incl MCA dopplers to monitor ?anaemia)
Mat med referral

79
Q

Interpretation of maternal immunity in parvovirus infection

A

IgG +ve, IgM -ve = immunity
IgG -ve, IgM +ve= very recent infection; retest in 1-2/52
IgG and IgM-ve = susceptible
IgGand IgM +ve = recent infection

80
Q

How to confirm fetal parvovirus infections

A

Amnio PCR
- IgM only made after 22/40, so amnio only useful in viraemic phase

81
Q

IgM -ve, IgG-ve and recent exposure to or sx of parvovirus

A

Bloods show no previous infection
If very recent exposure, re-check in 2-4 weeks
If remains negative, no current infection

82
Q

IgM -ve and IgG+ve and recent exposure to or sx of parvovirus

A

Past infection/ immune - reassure

83
Q

IgM +ve and IgG -ve/+ve and recent exposure to or sx of parvovirus

A

<20/40: check booking bloods as IgM + may represent IgM persistance. If positive, likely pre-pregnancy infection. Repeat serology to confirm seroconversion
>20/40: suggests recent infection
- refer to FM specialist
- serial ultrasound for MCA dopplers and signs of hydrops for 8-12/52
- If anaemia occurs, in utero resolution may occur spontaneously OR hydrops may develop
- Assess for intrauterine transfusion

84
Q

Management of HSV if first episode in1st or 2nd trimester

A

No evidence for incr risk spontaneous miscarriage
Should be seen by GUM
Rx: aciclovir 400mg tds x 5/7
- decreases duration and severity of disease, decreases duration of viral shedding
- paracetamol and topical lidocaine for sx relief
- Suppression rx from 36/40 - prophylactic aciclovir 400mg bd in 3rd trimester
- can have SVD, avoid invasive procedures
- augment delivery to minimise risk

85
Q

Management first episode HSV in third trimester

A

Rx aciclovir 400mg tds x 5/7, then cont prophylactic doses
CS delivery recommended if first episode within 6/52 of EDD

86
Q

Managing recurrent episode HSV in pregnancy

A

Rx episodes and give prophylactic rx in T3
Delivery by CS if presents. in T3
If infection w/in 6/40, risk of transmission 40%
Doesn’t require additional monitoring in pregnancy

87
Q

Intrapartum/ MOD in HSV

A

SVD if:
- recurrent HSV
- first episode in T1/2 or at least >6/52 since episode and no visible lesions
Offer CS if:
- visible lesions
Recommended CS:
- first episode within 6/52 of EDD

88
Q

Management of labour in primary HSV infection

A

IV aciclovir
No ARM/ FBS
Neonatal care

89
Q

Risk of NN HSV infection in recurrent HSV

A

0-3%, even if lesions present at delivery

90
Q

NB points in history when VZV exposure

A

Immunity?
Timing of exposure
Proximity-significant exposure:
- same room: >15min
-face to face:>5min
Type of varicella:
- high risk: disseminated, opthalmic, immunocompromised

91
Q

Duration of infectiousness in VZV

A

48hours before rash appears –> lesions crusted over. (+/- 5 days)

92
Q

Use of VZIG

A

Ideally w/in 96 hours, but can be within 10/7
Adverse reactions: pain/ erythema at IV site, anaphylaxis, subclinical infection
Second dose required if re-exposed 3/5 post last exposure

93
Q

Management of active VZV disease

A

W/in 24hours of rash - aciclovir 800mg x5/day x 7/7
- Caution <20/40- not licenced
>24 hours post exposure - don’t give
Fet med referral for detailed USS 5/52 post infection

94
Q

Maternal complications of VZV infection

A

Pneumonia (10-14%). Worse at increased GA, morbidity 14%
Hepatitis
Encephalopathy
Resp recurrence
Fever
Painful skin lesions -GAS superinfection
Delivery may precipitate haemorrhage

95
Q

Fetal complications VZV infection

A

In first 28/40 => fetal varicella syndrome
- scarring
- microcephaly
- cortical atrophy
- mental retardation
- bowel/ bladder dysfx
FVS not seen >28/40
- caused by in utero reactivation, not initial infection
No increased risk of miscarriage
Amnio - diagnostic of fetal infection
**time lag NB - FM review 5/52 post infection

96
Q

Neonatal complications VZV infection

A

Mat infection w/in 4/52 delivery - 50% babies affected
- severe if infection <1/52
Aim for delivery 7/7 after rash

97
Q

Epidemiology VZV

A

Seasonal: Jan - April
Incubation period: 8-21days
Spread: vesicles, droplet, airborne
Infective 2/7 before rash develops –> lesions crusted over (+/- 7/7)

98
Q

VZV igG levels - cut off

A

<100mlU/mL- administer PEP
- first line, aciclovir 800mgQDS from D7-D14 post exposure. IVIG for specific pts, on advice from microbio
>100mlU/mL - no need for PEP

99
Q

Associations with GBS

A

Maternal:
- endometritis
- chorioamnionitis
Fetal:
- >500000 PTB
- 100000 NNDs
- 46000 stillbirths/ IUD
- longterm neurodevelopmental delay

100
Q

Risk factors for EOGBS

A

Increased perinatal transmission
ROM > 18 hours
PROM
Prematurity
Intrapartum fever

101
Q

EOGBS

A

D0-6
Sepsis/ pneumonia
Late - D7-90 : meningitis

102
Q

Incidence of GBS

A

10-30% women colonised
36% babies born to GBS+ women become colonised
1-3% babies develop EOGBS bacteraemia

103
Q

Three strategies for GBS screening

A

Risk based
Intrapartum/ real-time testing
Routine screening at 35-37/40

104
Q

Who to offer intrapartum antibiotic prophylaxis to (re GBS)

A

SVD + prev baby with invasive GBS
Preterm labour <37/40
GBS detected in current pregnancy
Hx GBS prior to pregnancy * offer IAP or repeat testing
ROM > 18 hours

105
Q

Protocol for intrapartum antibiotic prophylaxis. (GBS)

A

3g benzylpenicillin IV stat
Then 1.5-1.8g IV 4hourly
Non-immed hypersensitivity: cefuroxime 1.5g IV 4 hourly
Immed allergy- clindamycin 900mg IV TDS OR vanc 15mg/kg BD (max 2g)

106
Q

Increased risks assoc w twin pregnancy

A

PET
Obs chole
PPH

107
Q

When should chorionicity be determined

A

<14/40

108
Q

When should twin pregnancy be referred to tertiary unit

A

Monochorionicity
TTTS
Growth discordance >18%
Higher order multiples
Single fetal demise + monochorionicity
- risk: 18% neuro defect, 12% death in remaining twin

109
Q

Monitoring in twin pregnancies

A

MC:
- USS 2/52 from 16/40 -growth and screening for TTTS
- TTTS < 26/40 - consider laser ablation
DC:
- USS 4/52 from 24/40
Cx length if prev risk factors

110
Q

Delivery of twin pregnancies

A

DCDA: 37 - 37+6/40
MCDA: 36 -36+6/40
MCMA: 32-34/40
SVD success: 77%
Twin 2- r/o CS 4%

111
Q

What is selective growth restriction

A

Growth discordance, w normal/ reverse/ absent/ cyclical UAD

112
Q

Incidence of growth discordance in twin pregnancy

A

15-25%

113
Q

How to calculate growth discordance

A

[(larger twin EFW- smaller twin EFW) x100]

114
Q

Causes of growth discordance

A

Mostly placental cause
? chromosomal cause

115
Q

Monitoring in growth discordant twins

A

> 18%: increased monitoring
20% : increased perinatal risk
2/52 UAD+ EFW
Check dopplers and DVP

116
Q

Delivery in growth discordant twins

A

Discordance, normal dopplers x 2 = deliver 34-36/40
Discordance, AREDF x 1 or 2 = deliver by 32/40
Discordance, intermittent AREDF =deliver by 32/40

117
Q

TTTS donor vs recipient

A

Donor: oligo, abnormal UAD, empty bladder, cardiac signs
Recipient: poly, abnormal UVD, cardiac signs

118
Q

Incidence of TTTS in MC twins

A

15%

119
Q

Parameters used in staging TTTS

A

UAD
MCA PSV
Ductus venosus doppler

120
Q

When is laser ablation recommended

A

TTTS detected < 26/40

121
Q

Monitoring in TTTS

A

Weekly USS: UAPI, MCA PSV, DV

122
Q

Delivery timing in TTTS

A

Post-treatment: 34-36/40

123
Q

Staging system used in TTTS

A

Quintero staging:
I. Significant discordance in amniotic fluid volumes
II. Bladder of donor twin not visible + severe oligo
III. Doppler critically abnormal in donor or recipient; typically abN UAD in donor and abN DV in recipient
IV. Ascites, pericardial or pleural effusions, scalp oedema or overt hydrops in recipient
V. One or both babies demised

124
Q

What is TAPS

A

Twin anaemia (donor) polycythaemia (recipient) syndrome
Form of TTTS
Unequal Hbs between twins
Can happen post ablation
Cause= small AVM in placenta
Differs from TTTS as LV remains the same

125
Q

Dx TAPS

A

Using MCA PSV
Donor: anaemia MCA >1.5
Recipient: polycythaemia MCA <1

126
Q
A

P2 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions